2026 ICD-10-CM Diagnosis Code T47.0X5AAdverse effect of histamine H2-receptor blockers, initial encounter
T47.0X5A is a billable ICD-10-CM diagnosis code for adverse effect of histamine H2-receptor blockers, initial encounter. The 7th character A marks it as an initial encounter code, used while the patient is receiving active treatment. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026) and groups to MS-DRG 917 through 918. The code is not accepted as a principal diagnosis by the Medicare Code Editor. Coders also document this condition as cimetidine adverse reaction. In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under Adverse effects of drugs and medicaments, initial encounter.
Code Identity
Code Classification
Code EditsBilling
Medicare Code Editor checks that affect claim validity for T47.0X5A.
Approximate SynonymsGuidance
Alternate terms and clinical phrases that map to this code.
- Cimetidine adverse reaction
- Famotidine adverse reaction
- H2 receptor antagonist adverse reaction
- Nizatidine adverse reaction
- Ranitidine adverse reaction
Coding GuidelinesGuidance
When coding an adverse effect of a drug that has been correctly prescribed and properly administered, assign the appropriate code for the nature of the adverse effect followed by the appropriate code for the adverse effect of the drug.
The appropriate 7th character is to be added to each code from block Poisoning by, adverse effect of and underdosing of agents primarily affecting the gastrointestinal system (T47). Use the following options for the applicable episode of care:
- A - initial encounter
- D - subsequent encounter
- S - sequela
Source: ICD-10-CM Official Guidelines for Coding and Reporting, FY 2026, published by CMS and the National Center for Health Statistics.
Clinical ClassificationClinical
AHRQ’s CCSR groups this code into broader clinical categories.
Clinical InformationClinical
Cimetidine
a histamine congener, it competitively inhibits histamine binding to histamine h2 receptors. cimetidine has a range of pharmacological actions. it inhibits gastric acid secretion, as well as pepsin and gastrin output.Famotidine
a competitive histamine h2-receptor antagonist. its main pharmacodynamic effect is the inhibition of gastric secretion.Nizatidine
a histamine h2 receptor antagonist with low toxicity that inhibits gastric acid secretion. the drug is used for the treatment of duodenal ulcers.Ranitidine
a non-imidazole blocker of those histamine receptors that mediate gastric secretion (h2 receptors). it is used to treat gastrointestinal ulcers.
Table of Drugs and ChemicalsClinical
Substances in the Table of Drugs and Chemicals that reference this code family. Always confirm in the Tabular List before coding.
| Substance | Accidental | Self-harm | Assault | Undetermined | Adverse Effect | Underdosing |
|---|---|---|---|---|---|---|
| Cimetidine | T47.0X1 | T47.0X2 | T47.0X3 | T47.0X4 | T47.0X5 | T47.0X6 |
| Famotidine | T47.0X1 | T47.0X2 | T47.0X3 | T47.0X4 | T47.0X5 | T47.0X6 |
| Nizatidine | T47.0X1 | T47.0X2 | T47.0X3 | T47.0X4 | T47.0X5 | T47.0X6 |
| Ranitidine | T47.0X1 | T47.0X2 | T47.0X3 | T47.0X4 | T47.0X5 | T47.0X6 |
| Roxatidine | T47.0X1 | T47.0X2 | T47.0X3 | T47.0X4 | T47.0X5 | T47.0X6 |
Patient EducationClinical
Drug Reactions
Most of the time, medicines make our lives better. They reduce aches and pains, fight infections, and control problems such as high blood pressure or diabetes. But medicines can also cause unwanted reactions, such as drug interactions, side effects, and allergies.
The full article covers:
- What is a drug interaction?
- What are side effects?
- What are drug allergies?
- How can I stay safe when taking medicines?
Read the full article at MedlinePlus
Courtesy of MedlinePlus, a service of the U.S. National Library of Medicine.
Convert T47.0X5A to ICD-9-CMHistory
The closest ICD-9-CM equivalents under the General Equivalence Mappings.
Code HistoryHistory
Questions About T47.0X5AOverview
Is T47.0X5A (Adverse effect of histamine H2-receptor blockers) a billable code?
Yes. This is a billable ICD-10-CM code, specific enough to report adverse effect of histamine H2-receptor blockers, initial encounter on HIPAA-covered claims from October 1, 2025 through September 30, 2026.
What does the 7th character A in T47.0X5A mean?
The final character A marks the initial encounter: use it while the patient is receiving active treatment for adverse effect of histamine H2-receptor blockers, such as an emergency visit or first evaluation.
What MS-DRG does T47.0X5A group to?
On inpatient claims, adverse effect of histamine H2-receptor blockers, initial encounter maps to MS-DRG 917, 918, with relative weights from 0.8571 to 1.5684 depending on complications. Higher weights mean higher Medicare reimbursement.
Can T47.0X5A be a principal diagnosis?
No. The Medicare Code Editor rejects this code as a principal diagnosis because adverse effect of histamine H2-receptor blockers, initial encounter describes a circumstance that influences health status rather than a current illness. Report it as a secondary diagnosis.
What is the ICD-9 equivalent of T47.0X5A?
Under the General Equivalence Mappings, adverse effect of histamine H2-receptor blockers, initial encounter converts to ICD-9-CM 995.29 (adv eff med/biol NEC/NOS) and E943.0 (adv eff antacids). The mapping is approximate, so confirm the match fits the documentation.
Footnotes
[1] Not chronic - A diagnosis code that does not fit the criteria for chronic condition (duration, ongoing medical treatment, and limitations) is considered not chronic. Some codes designated as not chronic are acute conditions. Other diagnosis codes that indicate a possible chronic condition, but for which the duration of the illness is not specified in the code description (i.e., we do not know the condition has lasted 12 months or longer) also are considered not chronic.
